
Bruce F Bebo
Articles
-
3 weeks ago |
neurologylive.com | Bruce F Bebo |Isabella Ciccone
WATCH TIME: 2 minutes"What often sets some of the prize winners apart is that these discoveries have led to something translational, something that has ultimately resulted in the development of disease-modifying or other therapies that benefit people living with MS.”Recognition of research in multiple sclerosis (MS) provides an opportunity to highlight the efforts of investigators who contribute to advancing clinicians’ understanding of the disease.
-
1 month ago |
neurologylive.com | Isabella Ciccone |Bruce F Bebo |Amit Bar-Or
Recent advancements in multiple sclerosis (MS) research have significantly enhanced clinicians’ understanding of the disease's pathogenesis and treatment.
-
1 month ago |
neurologylive.com | Bruce F Bebo |Isabella Ciccone
WATCH TIME: 5 minutes “I think we’ll look back—when the cures are found for MS—and we’ll see these lectures at the Academy meeting as milestones and significant jumps in our understanding of MS that led to those cures.” The John Dystel Prize for Multiple Sclerosis Research, presented by the National Multiple Sclerosis Society (the Society) in partnership with the American Academy of Neurology (AAN), honors exceptional research that has significantly advanced the understanding, prevention,...
-
Feb 27, 2025 |
neurologylive.com | Bruce F Bebo |Isabella Ciccone
WATCH TIME: 5 minutes"Studies published just a year or so ago queried electronic medical records using AI algorithms to look for patterns in healthcare utilization and groups of people who went on to develop MS compared [with] those who did not.
-
Feb 27, 2025 |
neurologylive.com | Bruce F Bebo |Isabella Ciccone
WATCH TIME: 4 minutes "Even when you have [patients] on these high-efficacy therapies and almost completely suppressing relapses, you still notice this slow progression." The 2025 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, held February 27 to March 1, in West Palm Beach, Florida, spotlights the latest breakthroughs in MS research, with a strong focus on smoldering neuroinflammation, progression independent of relapse activity (PIRA), and innovative...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →